WuXi Biologics plans to expand its new integrated biologics conjugation solution center to include commercial manufacturing in Wuxi City, China. Last June, WuXi Biologics announced the building of an integrated biologics conjugation solution center, including process development and clinical manufacturing for Antibody-Drug Conjugates (ADCs) drug substance and drug product. This center is expected to initiate GMP manufacturing later this year. The new 5.5-acre expansion will enable cGMP commer...